These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2225 related articles for article (PubMed ID: 23831213)
1. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213 [TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539 [TBL] [Abstract][Full Text] [Related]
3. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases]. Schildge J; Klar B; Hardung-Backes M Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558 [TBL] [Abstract][Full Text] [Related]
4. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163 [TBL] [Abstract][Full Text] [Related]
5. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Ishii H; Mukae H; Kadota J; Fujii T; Abe K; Ashitani J; Kohno S Respiration; 2005; 72(1):39-45. PubMed ID: 15753633 [TBL] [Abstract][Full Text] [Related]
7. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187 [TBL] [Abstract][Full Text] [Related]
8. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745 [TBL] [Abstract][Full Text] [Related]
9. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis. Capelli A; Di Stefano A; Gnemmi I; Donner CF Eur Respir J; 2005 Apr; 25(4):701-7. PubMed ID: 15802346 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417 [TBL] [Abstract][Full Text] [Related]
11. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Prasse A; Pechkovsky DV; Toews GB; Jungraithmayr W; Kollert F; Goldmann T; Vollmer E; Müller-Quernheim J; Zissel G Am J Respir Crit Care Med; 2006 Apr; 173(7):781-92. PubMed ID: 16415274 [TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage in idiopathic interstitial lung diseases. Nagai S; Handa T; Ito Y; Takeuchi M; Izumi T Semin Respir Crit Care Med; 2007 Oct; 28(5):496-503. PubMed ID: 17975777 [TBL] [Abstract][Full Text] [Related]
13. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease. Jehn LB; Costabel U; Boerner E; Wessendorf TE; Theegarten D; Taube C; Bonella F Immunobiology; 2022 Sep; 227(5):152258. PubMed ID: 35998415 [TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs). Kopiński P; Balicka-Ślusarczyk B; Dyczek A; Szpechciński A; Przybylski G; Jarzemska A; Wandtke T; Jankowski M; Iwaniec T; Chorostowska-Wynimko J Folia Histochem Cytobiol; 2011; 49(4):636-45. PubMed ID: 22252758 [TBL] [Abstract][Full Text] [Related]
15. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Shinoda H; Tasaka S; Fujishima S; Yamasawa W; Miyamoto K; Nakano Y; Kamata H; Hasegawa N; Ishizaka A Respiration; 2009; 78(3):285-92. PubMed ID: 19270434 [TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease. Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946 [No Abstract] [Full Text] [Related]
17. Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia. Cai M; Bonella F; Dai H; Sarria R; Guzman J; Costabel U Immunobiology; 2013 Jun; 218(6):930-7. PubMed ID: 23199585 [TBL] [Abstract][Full Text] [Related]
18. The role of high mobility group box1 in pulmonary fibrosis. Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281 [TBL] [Abstract][Full Text] [Related]
19. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis. Lin FC; Chen YC; Chang SC Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553 [TBL] [Abstract][Full Text] [Related]